• HyperScript™ Reverse Transcriptase: Superior cDNA Synthesis

  2026-05-10

  HyperScript™ Reverse Transcriptase, engineered by APExBIO, sets a new standard for cDNA synthesis by enabling robust reverse transcription of RNA templates with extensive secondary structures and low abundance. Leveraging innovations from M-MLV Reverse Transcriptase and recent qPCR assay advances, this enzyme streamlines workflows for sensitive and high-fidelity RNA to cDNA conversion.

• Haloprogin: Broad-Spectrum Topical Antifungal Mechanisms Exp

  2026-05-09

  The foundational 1970 study established Haloprogin as a potent topical antifungal with unique efficacy against dermatophytes, Candida, and certain Gram-positive bacteria. This work defined its broad-spectrum potential, set pivotal MIC/MFC benchmarks, and informed protocol design for both in vitro and in vivo infection models.

• Amt-1 Enhances Antiviral Defense Against Influenza via Nrf2/

  2026-05-08

  This study introduces Amt-1, a novel amantadine derivative, that suppresses influenza A virus by combining direct M2 ion channel inhibition with Nrf2/HO-1-mediated anti-inflammatory effects. Its dual mechanism improves efficacy against resistant strains and limits lung inflammation, marking a significant advance in host-directed antiviral strategies.

• DNase I (RNase-free): Elevating DNA Removal in RNA Workflows

  2026-05-08

  DNase I (RNase-free) from APExBIO sets the benchmark for precise, RNase-free DNA removal in sensitive molecular workflows. Its cation-dependent versatility, robust activity, and proven integration into advanced protein purification protocols empower high-fidelity RNA extraction and downstream assays.

• Bazedoxifene: Precision SERM for Signal Pathway Dissection i

  2026-05-07

  Explore Bazedoxifene, a selective estrogen receptor modulator, as a precision tool for dissecting estrogen and IL-6/GP130 signaling in postmenopausal osteoporosis and oncology research. This article uniquely integrates molecular pharmacology with translational assay guidance.

• Scenario-Driven Lab Solutions with AO/PI Double Staining Kit

  2026-05-07

  This evidence-based guide explores common laboratory challenges in cell viability, apoptosis, and necrosis assays, demonstrating how the AO/PI Double Staining Kit (SKU K2238) delivers robust, reproducible, and data-backed solutions. Scenario-driven Q&As provide actionable insights rooted in peer-reviewed literature and best practices for biomedical researchers and lab technicians.

• Tetraethylammonium Chloride: Applied Workflows in Vascular &

  2026-05-06

  Tetraethylammonium chloride (TEAC) enables precise interrogation of potassium channel function, underpinning a spectrum of workflows from vascular pharmacology to metabolic disease modeling. This article details experimental enhancements, troubleshooting, and advanced use-cases—bridging peer-reviewed insights and APExBIO’s high-purity product reliability.

• Direct Mouse Genotyping: Enabling Mechanistic Liver Research

  2026-05-06

  This thought-leadership article bridges mechanistic insights into STING signaling in cholestatic liver disease with strategic guidance on high-throughput genotyping. Integrating recent literature on conjugated bile acids, it demonstrates how the Direct Mouse Genotyping Kit empowers translational researchers to accelerate genetic screening and mechanistic validation. The article uniquely synthesizes emerging pathophysiology, practical workflow optimizations, and the competitive landscape, with actionable recommendations for biomedical and translational scientists.

• Translating Sodium Dicloxacillin Monohydrate: Mechanism to M

  2026-05-05

  This expert article offers translational researchers a multi-dimensional analysis of sodium dicloxacillin monohydrate—bridging mechanistic insight, experimental best practices, and strategic guidance for Gram-positive bacterial infection models. By integrating robust literature, product intelligence, and forward-looking recommendations, it provides a blueprint for leveraging APExBIO’s sodium dicloxacillin monohydrate in both in vitro and in vivo contexts, emphasizing reproducibility, clinical alignment, and workflow optimization.

• Machine Learning-Driven Discovery of Senolytics: Implication

  2026-05-05

  The referenced study pioneers a machine learning approach to senolytic discovery, identifying three potent compounds with efficacy comparable to known agents. This work significantly reduces the cost and scale required for early-phase drug screening, offering a new paradigm for the targeted elimination of senescent cells in cancer and aging research.

• Diphenyleneiodonium Chloride: Precision Probe for Redox and

  2026-05-04

  Diphenyleneiodonium chloride (DPI) uniquely integrates robust NADH oxidase inhibition with advanced cAMP signaling modulation, enabling high-resolution dissection of redox and GPCR pathways. This article delivers actionable workflows, troubleshooting strategies, and translates recent plant-pathogen research into practical assay design for biomedical and plant scientists.

• BRCAness and Olaparib Sensitivity in Mesothelioma: Profiling

  2026-05-04

  Borchert et al. provide a comprehensive gene expression analysis of homologous recombination repair (HRR) defects in malignant pleural mesothelioma (MPM), revealing that a subset of patients exhibit BRCAness phenotypes predictive of olaparib sensitivity. Their findings support HRR profiling as a route to stratified, apoptosis-inducing combination therapies in MPM.

• Tigecycline Workflows: Precision Tools for Multidrug-Resista

  2026-05-03

  Tigecycline stands apart as a glycylcycline antibiotic with robust activity against multidrug-resistant bacteria, proven across in vitro and in vivo models. This article delivers step-by-step protocols, troubleshooting strategies, and real-world optimizations—grounded in recent molecular epidemiology—to empower translational research and clinical relevance.

• Imidazoline Antagonists Boost Insulin by Blocking K+ Channel

  2026-05-02

  Jonas et al. (1992) demonstrated that imidazoline antagonists of α2-adrenoceptors stimulate insulin release in mouse pancreatic β-cells by directly inhibiting ATP-sensitive potassium channels, rather than solely via adrenoceptor blockade. This mechanistic insight refines our understanding of ion channel regulation in insulin secretion and has significant implications for diabetes research and ion channel pharmacology.

• Thiazovivin: Practical Guidance for ROCK Inhibition in Stem

  2026-05-01

  Thiazovivin is a ROCK inhibitor that enhances induced pluripotent stem cell generation and improves the survival of human embryonic stem cells after dissociation. It is best suited for workflows requiring efficient reprogramming or maintenance of stem cells, but should not be used outside research applications or for long-term solution storage.

15745 records 12/1050 page Previous Next First page 上5页 1112131415 下5页 Last page